Adenoid Cystic Carcinoma Research Foundation

The Adenoid Cystic Carcinoma Research Foundation (ACCRF) plans, coordinates and supports biomedical research to accelerate the development of improved therapies and a cure for adenoid cystic carcinoma (ACC), a rare cancer of secretory glands that afflicts approximately 11,000 people in the United States. The foundation is a pioneer in patient-driven research, galvanizing a cutting-edge research effort that is leading to new treatment approaches for a deadly disease with no approved drugs.